Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "Monkeypox"
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase I Trial of an Investigational Small Pox Medication
Conditions: Orthopoxviral Disease;   Smallpox;   Monkey Pox
Interventions: Drug: ST-246 Days 1 - 3;   Drug: ST-246 Days 11 - 13
2 Available Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Conditions: Smallpox;   Monkeypox
Intervention: Drug: Tecovirimat
3 Completed A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
Conditions: Male or Female Patients With a Serious or Immediately Life-threatening;   Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or;   Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for;   Whom no Comparable or Satisfactory Alternative Therapy is Available
Intervention: Drug: CMX001
4 Withdrawn SIGA-246 to Treat Smallpox
Condition: Vaccinia
Intervention: Drug: Vaccine: SIGA-246

Indicates status has not been verified in more than two years